Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by 2b7f6fabon Dec 31, 2022 7:58pm
260 Views
Post# 35198752

RE:RE:Vaccine Platform

RE:RE:Vaccine PlatformAlways appreciated reading your comments but to suggest "the relatively high efficacy rates of the mRNA vaccines,"  makes me wonder.  These mRNA vaccines have butchered millions already.  Even the head of the WHO is quoted as saying these vaccines are being used to murder children.  Just no idea where you are coming from with the idea these vaccines are efficatious.

CancerSlayer wrote:

enriquesuave wrote: If successful, the vaccine platform could be a game changer for both Covid-19 and any other potential viral threat.  One must realize that it took like months before  mRNA tech comes up with a vaccine targeting only one Antigen. With a PDT platform, vaccine could be produced in days and would be a whole virus vaccine where every viral antigen would be targeted upon vaccination.  The fastest go to platform for vaccines.  Just wanted to share a thought.  All IMHO 

 

Considering the already crowded market of injectable vaccines & the relatively high efficacy rates of the mRNA vaccines, there remains a great opportunity to explore the intranasal/inhalation route in order to better stimulate/boost one's mucosal immunity.  Depending on the formulation (i.e. dry powder vs liquid), using the inhaled or intranasal route may also require a significantly smaller volume of vaccine, which would make it more cost-effective & hence accessible to a larger number of patients.  I also strongly believe in the potential of this tech to not only prevent moderate/serious Covid illness, but also to treat existing infection/illness via the same inhaled route.  The potential to treat other viruses only adds to its value.  Can't wait to see this develop...could potentially match (or even outperform) its oncological potential.  Good luck...



<< Previous
Bullboard Posts
Next >>